NCT03685695
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +24 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
Clinical trial condition
Ovarian Serous Tumor
Explore clinical trials studying Ovarian Serous Tumor. Study availability and eligibility vary by location and protocol.
4 public trials
0 recruiting studies
Ovarian Serous Tumor trial results
NCT02520115
- Conditions
- Adnexal Diseases, Adnexal Mass, Borderline Ovarian Epithelial Tumor, +19 more
- Locations
-
- Karmanos Cancer Institute at McLaren Bay Region, Bay City Bay City, Michigan, United States
- Wayne State University/Karmanos Cancer Institute Detroit, Michigan, United States
NCT02446600
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +27 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
- Alaska Women's Cancer Care Anchorage, Alaska, United States
- Providence Alaska Medical Center Anchorage, Alaska, United States
Active, Not Recruiting
Gemcitabine Hydrochloride Alone or With M6620 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
NCT02595892
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +18 more
- Locations
-
- Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- UC San Diego Moores Cancer Center La Jolla, California, United States
- UC San Diego Medical Center - Hillcrest San Diego, California, United States